Dare Bioscience Analyst Ratings
Dare Bioscience Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/13/2022 | 652.77% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
| 12/01/2022 | 545.23% | JonesTrading | → $6 | Initiates Coverage On | → Buy |
| 04/01/2022 | 545.23% | HC Wainwright & Co. | $5 → $6 | Maintains | Buy |
| 06/30/2021 | 1082.92% | Roth Capital | $9 → $11 | Maintains | Buy |
| 12/18/2020 | 437.69% | HC Wainwright & Co. | → $5 | Initiates Coverage On | → Buy |
| 04/28/2020 | 706.54% | Brookline Capital | → $7.5 | Initiates Coverage On | → Buy |
| 08/17/2018 | 222.62% | Maxim Group | → $3 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 12/13/2022 | 652.77% | HC Wainwright公司 | $6 → $7 | 維護 | 買 |
| 12/01/2022 | 545.23% | Jones Trading | → $6 | 開始承保 | →購買 |
| 04/01/2022 | 545.23% | HC Wainwright公司 | $5 → $6 | 維護 | 買 |
| 06/30/2021 | 1082.92% | 羅斯資本 | $9 → $11 | 維護 | 買 |
| 12/18/2020 | 437.69% | HC Wainwright公司 | → $5 | 開始承保 | →購買 |
| 04/28/2020 | 706.54% | 布魯克林資本 | → $7.5 | 開始承保 | →購買 |
| 08/17/2018 | 222.62% | Maxim集團 | → $3 | 開始承保 | →購買 |
What is the target price for Dare Bioscience (DARE)?
Dare Bioscience(DARE)的目標價格是多少？
The latest price target for Dare Bioscience (NASDAQ: DARE) was reported by HC Wainwright & Co. on December 13, 2022. The analyst firm set a price target for $7.00 expecting DARE to rise to within 12 months (a possible 652.77% upside). 3 analyst firms have reported ratings in the last year.
戴爾生物科學公司(納斯達克代碼：DARE)的最新目標價是由HC Wainwright&Co.於2022年12月13日報道的。這家分析公司將目標價定為7美元，預計12個月內敢於上漲(可能上漲652.77%)。3家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Dare Bioscience (DARE)?
Dare Bioscience(DARE)的最新分析師評級是多少？
The latest analyst rating for Dare Bioscience (NASDAQ: DARE) was provided by HC Wainwright & Co., and Dare Bioscience maintained their buy rating.
納斯達克(代碼：DARE)的最新分析師評級由HC Wainwright&Co.提供，Dare Bioscience維持買入評級。
When is the next analyst rating going to be posted or updated for Dare Bioscience (DARE)?
Dare Bioscience(DARE)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dare Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dare Bioscience was filed on December 13, 2022 so you should expect the next rating to be made available sometime around December 13, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公開財務報表，與Dare Bioscience的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Dare Bioscience的上一次評級是在2022年12月13日提交的，所以你應該預計下一次評級將在2023年12月13日左右提供。
Is the Analyst Rating Dare Bioscience (DARE) correct?
分析師對Dare Bioscience(DARE)的評級正確嗎？
While ratings are subjective and will change, the latest Dare Bioscience (DARE) rating was a maintained with a price target of $6.00 to $7.00. The current price Dare Bioscience (DARE) is trading at is $0.93, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Dare Bioscience(DARE)評級保持不變，目標價在6.00美元至7.00美元之間。Dare Bioscience(DARE)目前的交易價格為0.93美元，超出了分析師的預測區間。